Dr. Will Cole emphasizes the importance of careful use of GLP-1 medications and peptide therapy, advocating for micro-dosing combined with lifestyle changes rather than high doses. He highlights the need for a balanced approach to metabolic health, addressing underlying lifestyl…
As prescriptions for GLP-1 medications surge among adolescents, parents face important considerations regarding their children's health. This article explores the benefits and pot…
A recent review examines the effects of GLP-1 medications, particularly semaglutide, on muscle health in postmenopausal women. While these medications can aid in weight loss, they…
This article explores the influence of GLP-1 receptor agonists on self-control and weight management, challenging traditional views that attribute weight issues solely to individu…
In a recent conversation, Dr. Tyna Moore addresses the complexities surrounding GLP-1 medications, advocating for their use at low doses. She counters common misconceptions about…
Research into GLP-1 medications, such as Ozempic and Wegovy, indicates they may play a role in reducing cancer risk by improving metabolic health, but the evidence remains mixed a…
This article explains the concept of controlling for variables in scientific studies, highlighting its significance in assessing the credibility of research findings. It discusses…
Access to obesity drugs in the UK is divided between a slow NHS rollout of tirzepatide and a rapidly growing private market. The NHS aims to provide access over 12 years, starting…
Dozens of lawsuits have been filed against the manufacturers of GLP-1 drugs like Ozempic and Wegovy, alleging that users were not adequately warned about the risk of a rare type o…
During a recent segment on the Today show, co-host Craig Melvin humorously responded to Dylan Dreyer's inquiry about whether he has used GLP-1 medications for weight loss. The exc…
A recent study published in Childhood Obesity highlights a concerning trend among children taking GLP-1 medications for weight management and diabetes. The study found that nearly…
Recent lawsuits have emerged against the makers of GLP-1 drugs like Ozempic and Wegovy, alleging insufficient warnings about a rare vision loss condition known as NAION. While stu…
Sofia Carson has come under fire for her appearance at the LACMA Art+Film Gala, with fans expressing concern over Hollywood's extreme beauty standards. The backlash highlights a g…
Beauty companies are racing to address the newly coined term 'Ozempic face' as they develop treatments for facial volume loss linked to rapid weight loss, further complicating the…
Fitness coach Jacob Zemer outlines key strategies to help adults slow muscle loss as they age. He emphasizes the importance of strength training, adequate protein intake, and qual…
NVIDIA and Eli Lilly have both reported impressive quarterly earnings, showcasing their respective growth potential. NVIDIA's revenue surged by over 105% year-over-year, driven by…
U.S. grocery prices have experienced significant increases in recent years, a phenomenon described as the 'rockets and feathers' effect. While food price inflation peaked at 11.4%…